Novel natural vanilloid receptor agonists: new therapeutic targets for drug development

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.20, Iss.11, 1999-11, pp. : 459-465

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serotonin-2 Receptor Agonists as Novel Ocular Hypotensive Agents and their Cellular and Molecular Mechanisms of Action: Novel Drug Targets for Glaucoma Treatment

Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. : 978-993

Bentham Science Publishers

Access to resources Recommend Favorite

Endocannabinoids New Targets for Drug Development

Current Pharmaceutical Design, Vol. 6, Iss. 13, 2000-09 ,pp. : 1361-1380

Bentham Science Publishers

Access to resources Recommend Favorite

TRPV1 (vanilloid receptor, capsaicin receptor) agonists and antagonists

By Appendino Giovanni Muñoz Eduardo Fiebich Bernd L

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 12, 2003-12 ,pp. : 1825-1837

Informa Healthcare

Access to resources Recommend Favorite

Apoptosis: Potential Therapeutic Targets for New Drug Discovery

Current Medicinal Chemistry, Vol. 14, Iss. 22, 2007-09 ,pp. : 2369-2379

Bentham Science Publishers

Access to resources Recommend Favorite

TNF-receptor-associated factors as targets for drug development

By Zapata Juan M

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 3, 2003-06 ,pp. : 411-425

Informa Healthcare

Access to resources Recommend Favorite